Nanotechnology in Cancer Diagnosis
Cancer is an extremely complicated disease that spreads through a multi-step process that involves angiogenesis, resistance to apoptosis (cell death), unchecked cell growth, changes in cellular signalling, tissue invasion, and metastasis. Cancer typically starts as a localised tumour that has the potential to spread (metastasise) to other parts of the body, making care challenging. The incidence and death of cancer are rising globally.
Nanotechnology is the study of molecules at the atomic, molecular, and supramolecular levels (1–100 nm) to determine their properties and how they might be used to improve human health. Modern biology and medicine are advancing nanotechnology to create more nanoscale materials that can be used in biological systems. Nanotechnology uses nanoscale principles and approaches to understand biosystems.
The advancement of nanotechnology opens up new possibilities for biomedicine. The innovative biosensor based on bio-nanotechnology can be used for early tumour identification and treatment because of the distinctive physical and chemical features of nanomaterials. The primary areas of use for nanomedicine today are tissue engineering and regenerative medicine, accurate illness diagnosis and real-time monitoring, cutting-edge imaging and analytic methods, multifunctional drug delivery systems, and targeted therapy. Cancer will be accurately diagnosed and treated with the use of nanotechnology.
Due to erroneous diagnosis and illness recurrence, malignant tumours are one of the most significant risks to human health. Nanotechnology offers efficient support for cancer treatment and drug development as a new technique for cancer diagnostics and treatment through targeted and gene therapy. An innovative platform for cancer research is provided by nanotechnology.
ALSO READ – A-Z of Skin Cancer: Screening, Preventions and Risks Involved
Nanotechnology and Medicine
To help in the early identification of cancer, imaging methods and the morphological study of tissues (histopathology) or cells (cytology) are currently used. Imaging technologies make it possible to see tissue changes and identify cancerous cells. However, because these procedures take a long period, cancer cells may have time to grow and infiltrate tissue.
In addition to creating a new kind of real-time molecular imaging technology, fresh imaging and analysis approaches can be created based on magnetic nanomaterials to enhance the level of pathological tissue monitoring that is currently available. Based on nanotechnology, a multimodal drug delivery system with targeting functionality can be created, allowing for improved therapeutic efficacy and an expansion of the range of currently available medicinal therapies. It is also possible to efficiently lessen the cytotoxic effects of conventional medication compounds. Nanotechnology and medical technology can be used to extend therapeutic options, raise the standard of care, and significantly advance the field of medicine.
Cancer Diagnosis and Tumour Therapy
Currently, the most popular cancer treatment options are chemotherapy, surgery, radiation, and combinations of these. However, these techniques have serious flaws, such as non-specificity and toxicity, among others. Modern medicine aims to maximise drug pharmacological activity and reduce any potential negative effects. The medicine must have a high local concentration at the site of the tumour and a low local concentration in healthy tissues to prevent any unintended reactions. The use of nanotechnology in cancer treatment has the potential to get beyond the limitations of current treatments. The amount of drug needed to have a therapeutic effect can be greatly reduced by using nanotechnology, and the drug concentration at the cancer location can be increased without harming healthy cells.
The innovative biosensor based on nanotechnology can increase the sensitivity of clinical diagnostics in comparison to conventional approaches, allowing for the earlier and more precise detection of particular problematic tissues or organs. The nano-biotechnology-based cell biosensor can identify various tumour cell types quickly and with great sensitivity, and it can also assess the tumour cells’ medication resistance. The immunoassay microfluidic chip can effectively identify various significant cancer indicators, such as a carcinoembryonic antigen, in human blood during clinical diagnosis.
ALSO READ – The H3N2 Virus: Latest News, Symptoms and Prevention
The study of disease treatment has advanced significantly thanks to nanotechnology. Several innovative treatments have been created using the magnetocaloric (magnetothermal) effect and photothermal effect of certain nanomaterials. For the imaging and diagnosis of tumour lesions, in particular, superparamagnetic magnetic materials can be used to obtain great sensitivity. Additionally, the temperature can be raised to 40–45°C under the influence of an external magnetic field to kill tumour cells. Some complex tasks, like intracellular medicine administration, power generation, and even cleaning up the toxic deposits in blood arteries, can be accomplished through the development of nanomedical devices.
Nanomaterials have a natural advantage as drug transporters due to their large specific surface area, surface and interface effect, and other factors. Studies conducted in vivo and in vitro revealed that nano-drug complexes can improve the cytotoxicity of medications for tumour cells and can considerably increase the effective concentration of chemotherapeutic agents in tumour cells. Additionally, the nano-drug combination has improved the safety of chemotherapy medications by having no noticeable negative effects on the experimental rats’ normal visceral tissues.
Conclusion
A promising use of nanotechnology is in the detection, management, and prognosis of cancer. There are undoubtedly still a lot of issues to be resolved before clinical practice. It is important to consider the safety and biocompatibility of nanomaterials, including how they interact with the human body. It is important to evaluate the effect on genetics or reproduction. The targeting and detection sensitivity of nanomaterials should be increased, and the rate of its application should also be accelerated, to prepare new materials or change the structure of existing materials. These currently available nanocomposite medicines can have a wider range of applications.
For further reference:
